LITH US Lithium Corporation (CE)

INFORMATION STATEMENT

U.S. LITHIUM CORP.

12340 Seal Beach, Blvd. Suite B-190

Seal Beach, CA  90740

INFORMATION STATEMENT AND NOTICE OF ACTIONS TAKEN

BY WRITTEN CONSENT OF THE MAJORITY SHAREHOLDERS

OF THE COMMON STOCK OF THE CORPORATION

THIS IS NOT A NOTICE OF A MEETING OF STOCKHOLDERS

 AND NO STOCKHOLDERS' MEETING WILL BE HELD

 TO CONSIDER THE MATTERS DESCRIBED HEREIN.

This Information Statement is being furnished to you solely for the purpose of informing stockholders of the matters described herein in compliance with Regulation 14C of the Exchange Act.

GENERAL

This Information Statement is being furnished to all holders of the common stock of U.S. Lithium Corp. (the "Company") as of January 27, 2020 in connection with the action taken by written consent of holders of a majority of the outstanding voting power of the Company to authorize a change in the Company’s name. The name will be changed from U.S. Lithium Corp. to BioELife Corp.

 OUTSTANDING VOTING SECURITIES

Our authorized capital stock consists of 500,000,000 shares of Common Stock, par value $0.001 per share, of which 9,409,970 shares were outstanding as of January 27, 2020.  The Company has no other class of stock authorized.

VOTE REQUIRED

Our ability to undertake the name change without a meeting of our Shareholders is authorized by Section 78.320 of the Nevada Revised Statutes. The Nevada Revised Statutes generally provides that a Nevada corporation may substitute for action on a matter by its shareholders at a meeting the written consent of the holders of outstanding shares of capital stock holding at least a majority of the voting power of the Company’s outstanding capital stock. In accordance with this provision, we obtained the written consent of the holders of a majority of our issued and outstanding shares to the name change. As a result of the action of these shareholders, we are not soliciting proxies, and there will be no further shareholder action on the name change. Holders of record of the Company’s Common Stock are entitled to notice of the action taken by written consent approving the name change.

(1)Richard Smith is owner of Windward International LLC and therefore is beneficial owner of 905,898 shares or 9.63% of U.S. Lithium Corp. He is the father of Christopher R. Smith. 

(2)Renate Panov is owner of Moonlight Ventures and therefore is beneficial owner of 470,000 shares or 4.99% of U.S. Lithium Corp.  

(3)Phillip Arthur Hickinbottom is owner of Olive Green Holdings and therefore is beneficial owner of 470,000 shares or 4.99% of U.S. Lithium Corp.  

(4)Daria Volozhaninova is owner of The Magic Owl Corp. and therefore is beneficial owner of 329,949 shares or 3.51% of U.S. Lithium Corp. 

(5)Simon Kenneth Hall is owner of Ravenhill International Holdings Investments and therefore is beneficial owner of 910,257 shares or 9.67% of U.S. Lithium Corp. 

(6)Maria Aracena Gomez is owner of Red Hibiscus International Ltd and therefore is beneficial owner of 470,000 shares or 4.99% of U.S. Lithium Corp. 

(7)Andrew Peter Balchin is owner of MKB Consultancy International and therefore is beneficial owner of 470,000 shares or 4.99% of U.S. Lithium Corp. 

(8)Stefano Bertamini is owner of SPB Capital and therefore is beneficial owner of 100,000 shares or 1.06% of U.S. Lithium Corp. 

(9)Andrew Scotti is the executor of the Estate of Josephine Scotti which owns 75,000 shares or 0.80% of U.S. Lithium Corp. 

(10)Christopher R. Smith is owner of POP Holdings Ltd. and therefore is beneficial owner of 447,500 shares or 4.76% of U.S. Lithium Corp. He is the son of Richard Smith. 

ACTIONS TO BE TAKEN

This Information Statement contains a brief summary of the material aspects of the action approved by the Board and the holders of a majority of the outstanding voting capital stock of the Company:

APPROVING AND ADOPTING A CHANGE OF NAME FOR THE CORPORATION. THE NAME WILL BE CHANGED FROM U.S. LITHIUM CORP. TO BIOELIFE CORP.  THERE WILL BE NO OTHER CHANGE TO THE ARTICLES OF INCORPORATION.

RECOMMENDATION OF THE BOARD OF DIRECTORS

The Board of Directors believes that the stockholders of the Company will benefit from the name change because the new name better reflects the primary focus of our business activities which is the purchase, marketing, distribution, and sales of hemp and CBD oils and products.

The name change will not change or affect any other provision of our Articles of Incorporation.

SECURITY OWNERSHIP OF CERTAIN

BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth certain information concerning the number of shares of our Common Stock owned beneficially as of January 27, 2020, by: (i) each of our director(s); (ii) each of our named executive officer(s); and (iii) each person or group known by us to beneficially own more than 5% of our outstanding shares of common stock. Unless otherwise indicated, the shareholders listed below possess sole voting and investment power with respect to the shares they own.

A beneficial owner of a security includes any person who, directly or indirectly, through any contract, arrangement, understanding, relationship, or otherwise has or shares: (i) voting power, which includes the power to vote, or to direct the voting of shares; and (ii) investment power, which includes the power to dispose or direct the disposition of shares. Certain shares may be deemed to be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to dispose of the shares). In addition, shares are deemed to be beneficially owned by a person if the person has the right to acquire the shares (for example, upon exercise of an option) within 60 days of the date as of which the information is provided. In computing the percentage ownership of any person, the amount of shares outstanding is deemed to include the amount of shares beneficially owned by such person (and only such person) by reason of these acquisition rights. As of January 27, 2020, there were 9,409,970 shares of our common stock issued and outstanding.

DISSENTER’S RIGHTS OF APPRAISAL

The Stockholders have no dissenter’s rights under Nevada Law, the Company’s Articles of Incorporation, or the Company’s By-Laws to dissent from the name change.

INTEREST OF CERTAIN PERSONS IN MATTERS TO BE ACTED UPON

No director, executive officer, nominee for election as a director, associate of any director, executive officer or nominee or any other person has any substantial interest, direct or indirect, by security holdings or otherwise, in the proposed name change action, which is not shared by all other stockholders.

FORWARD-LOOKING STATEMENTS

This Information Statement may contain certain “forward-looking” statements (as that term is defined in the Private Securities Litigation Reform Act of 1995 or by the U.S. Securities and Exchange Commission in its rules, regulations and releases) representing our expectations or beliefs regarding our company. These forward-looking statements include, but are not limited to, statements concerning our operations, economic performance, financial condition, and prospects and opportunities. For this purpose, any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate,” “might,” or “continue” or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. These statements, by their nature, involve substantial risks and uncertainties, certain of which are beyond our control, and actual results may differ materially depending on a variety of important factors, including factors discussed in this and other of our filings with the U.S. Securities and Exchange Commission.

WHERE YOU CAN FIND ADDITIONAL INFORMATION

The Company is subject to the informational requirements of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and in accordance therewith files reports, proxy statements and other information including annual and quarterly reports on Form 10-K and 10-Q (the “1934 Act Filings”) with the Securities and Exchange Commission (the “Commission”). Reports and other information filed by the Company can be inspected and copied at the public reference facilities maintained at the Commission at Room 1024, 450 Fifth Street, N.W., Washington, DC 20549. Copies of such material can be obtained upon written request addressed to the Commission, Public Reference Section, 450 Fifth Street, N.W., Washington, D.C. 20549, at prescribed rates. The Commission maintains a web site on the Internet (http://www.sec.gov) that contains reports, proxy and information statements and other information regarding issuers that file electronically with the Commission through the Electronic Data Gathering, Analysis and Retrieval System (“EDGAR”).